Readable research linked to original sources
Articles
Browse normalized, publication-ready research with direct links to its evidence and source.
Loading articles data…
Readable research linked to original sources
Browse normalized, publication-ready research with direct links to its evidence and source.
Loading articles data…
Readable research linked to original sources
Browse normalized, publication-ready research with direct links to its evidence and source.
5 articles
Newest firstBackgroundCurrent literature on Swedish child suicides relies on data from 2000 and onwards, at most. Presenting four decades of data, this paper aims to advance our understanding of youth suicide patterns. Focusing on the paediatric population, suicide statistics for age groups 10-17 and 10-14 were analysed for time trends. MethodsData extracted from the Swedish cause-of-death register covered 44 years (1980-2023…
Open article record in new tab ↗IntroductionAttention-deficit/hyperactivity disorder (ADHD) treatment and diagnoses show marked international and regional variation, not fully explained by underlying morbidity. In Denmark, earlier studies reported substantial regional differences, raising concerns about inequities in access to care. We examined nationwide patterns of ADHD medication use and diagnosis in 2024 and assessed system-level factors pot…
Open article record in new tab ↗The placebo response has a substantial impact on treatment outcome. However, data regarding mediators of the placebo response in children with autism spectrum disorder (ASD) are sparse. This retrospective study investigated possible mediators of the placebo response among participants of a placebo-controlled trial of cannabinoid treatment for behavioral problems in children with ASD (CBA trial, age 5-21 years). We…
Open article record in new tab ↗Autism spectrum disorder (ASD) is often associated with debilitating sleep disturbances. While anecdotal evidence suggests the positive effect of cannabinoids, randomized studies are lacking. Here, we report the effects of cannabinoid treatment on the sleep of 150 children and adolescents with ASD, as part of a double-blind, placebo-controlled study that assessed the impact of cannabinoid treatment on behavior (NC…
Background Endocannabinoid dysfunction in animal models of autism spectrum disorder (ASD) and accumulating, albeit anecdotal, evidence for efficacy in humans motivated this placebo-controlled double-blind comparison of two oral cannabinoid solutions in 150 participants (age 5-21 years) with ASD. Methods We tested (1) BOL-DP-O-01-W, a whole-plant cannabis extract containing cannabidiol and Δ9-tetrahydrocannabinol a…